2008美國先天性心臟病指南
《2008美國先天性心臟病指南》內(nèi)容簡介：
It is important that the medical profession play a central rolein critically evaluating the use of diagnostic procedures andtherapies introduced and tested for detection, management, orprevention of disease. Rigorous, expert **ysis of the avail-able data documenting absolute and relative benefits and risksof these procedures and therapies can produce guidelines thatimprove the effectiveness of care, optimize patient outcomes,and favorably affect the cost of care by focusing resources onthe most effective strategies.
《2008美國先天性心臟病指南》內(nèi)容預(yù)覽：
The American College of Cardiology Foundation （ACCF）and the American Heart Association （AHA） have jointlyengaged in the production of guidelines in the area ofcardiovascular disease since 1980. The American College ofCardiology （ACC）/AHA Task Force on Practice Guidelinesis charged with developing, updating, and revising practiceguidelines for cardiovascular diseases and procedures anddirects this effort. Writing committees are charged withassessing the evidence as an independent group of authors todevelop, update, or revise recommendations for clinicalpractice.
Experts in the subject under consideration have beenselected from both organizations to examine subject-specificdata and write guidelines in partnership with representativesfrom other medical practitioner and specialty groups. Writingcommittees are specifically charged to perform a formalliterature review, weigh the strength of evidence for oragainst particular treatments or procedures, and includeestimates of expected health outcomes where data exist.Patient-specific modifiers, comorbidities, and issues of pa-tient preference that might influence the choice of tests ortherapies are considered, as well as the frequency offollow-up and cost-effectiveness. When available, ***rma-tion from studies on cost is considered, but data on efficacyand clinical outcomes constitute the primary basis for recom-mendations in these guidelines.
點(diǎn)擊下載***：《2008美國先天性心臟病指南》
本站所注明來源為"愛愛醫(yī)"的文章，版權(quán)歸作者與本站共同所有，非經(jīng)授權(quán)不得轉(zhuǎn)載。
本站所有轉(zhuǎn)載文章系出于傳遞更多信息之目的，且明確注明來源和作者，不希望被轉(zhuǎn)載的媒體或個(gè)人可與我們
聯(lián)系z(mì)lzs@120.net，我們將立即進(jìn)行刪除處理
熱點(diǎn)圖文
-
嚴(yán)重顱腦損傷病人腸內(nèi)營養(yǎng)支持有何特點(diǎn)?
嚴(yán)重顱腦損傷病人多存在神志異常、昏迷、躁動(dòng)等,使之不能正常飲食,并給鼻飼置...[詳細(xì)]
-
嚴(yán)重顱腦損傷病人PN支持有何特點(diǎn)?
鑒于顱腦損傷后病人的特點(diǎn),胃腸外營養(yǎng)常被選作早期營養(yǎng)支持的手段。[詳細(xì)]
